Connect to other sites within the UBM Medica Network
PCOS Ups Health and Hospitalization Risks
Women with polycystic ovary syndrome (PCOS) are at increased risk for metabolic and heart diseases and nearly twice as likely to be hospitalized.
Weight Loss Before Bariatric Surgery in T2DM: GLP-1 Agonist Gets it Done
Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.
Lead With Weight Loss, Say New Endo Society Guidelines
The new guidelines signal a shift toward aggressive treatment for obesity as a primary disease and following with treatment for comorbidites that do not respond to weight loss.
Sleep Issues Feed Childhood Obesity
The odds of children becoming overweight go up with sleep-disordered breathing and short sleep duration, underscoring the need for early identification of these risk factors.
Less Severe Diabetes Has Better Remission With Surgery
After sleeve gastrectomy, obese patients with type 2 DM who have less severe disease do better than those who have more advanced disease. Surgery should be encouraged sooner rather than later.
Bariatric Surgery Cuts Diabetes Drug Use and Costs
The need for diabetes and cardiac medications is reduced significantly in obese patients who undergo weight-loss surgery, and so are their costs.
FDA Approves New Anti-Obesity Drug
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.